| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/18/2008 | EP1418922B1 Use of negatively charched phospholipids for the preparation of a medicament for treatment and/or prevention of macular degeneration |
| 06/18/2008 | CN101203251A 玻璃体可视化剂 Vitreous visualization agent |
| 06/18/2008 | CN101203243A Remedy for xanthoma |
| 06/18/2008 | CN101203236A Prophylactic or therapeutic agent for conrneal/conjunctival disease |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |
| 06/18/2008 | CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 06/18/2008 | CN101199858A Multiple target point small interference RNA cocktail agent for treating ophthalmic disease and preparing method thereof |
| 06/18/2008 | CN101199855A Skinniness hormone packing matter water solution and application thereof |
| 06/18/2008 | CN101199744A Oral administration Chinese medicine for treating tinnitus |
| 06/18/2008 | CN101199685A Smoked washing medicament for treating chronicity conjunctivitis |
| 06/18/2008 | CN101199673A Chinese medicine compound for treating light-headedness, eyes-drying and conjunctivitis and preparing method thereof |
| 06/18/2008 | CN101199659A Oral administration Chinese medicine for treating acute conjunctivitis |
| 06/18/2008 | CN101199619A Oral administration Chinese medicine for treating chronicity conjunctivitis |
| 06/18/2008 | CN101199600A Chinese medicine for treating nephrasthenia tinnitus |
| 06/18/2008 | CN101199584A Chinese medicine external patch for treating tinnitus deaf disease |
| 06/18/2008 | CN101199577A Eye medicament for treating conjunctivitis |
| 06/18/2008 | CN101199526A Improving eyesight guard inspect health care preparation and preparing method thereof |
| 06/18/2008 | CN101199505A Verapamil liposome and preparing method thereof |
| 06/18/2008 | CN100394932C Medicinal composition for treating keratitis caused by herpes zoster |
| 06/17/2008 | US7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 06/17/2008 | CA2391076C Solutions containing epinastin |
| 06/17/2008 | CA2294457C Pharmaceutical composition for application to mucosa |
| 06/17/2008 | CA2188892C Use of an yttrium salt in a compound for the treatment of sensitive skin |
| 06/12/2008 | WO2008070513A1 Modulation of polysialylated neural adhesion molecules (psa-ncam) as a regulator of ocular disease |
| 06/12/2008 | WO2008070169A2 Use of carboxyamidotriazole (cai) orotate in macular degeneration |
| 06/12/2008 | WO2008070132A2 Methods of use of trk receptor modulators |
| 06/12/2008 | WO2008068866A1 Ophthalmic composition |
| 06/12/2008 | WO2008015517A3 Ep2 agonists |
| 06/12/2008 | US20080139671 Applying clear liquid collagen and riboflavin crosslinker solution to eye tissue; exposing in situ to ultraviolet radiation dosages; reconstructing and strengthening |
| 06/12/2008 | US20080139652 Pharmaceutical Composition Containing Prostaglandin |
| 06/12/2008 | US20080139611 Use of [2-(7-Trifluoromethyl-quinolin-4-ylamino)-phenyl]-acetic acid or esters or salts thereof for example; pain, fever, or inflammation, a proliferative disorder, skin disorders, eye disorders; compound disclosed in US patent 3,637,710 |
| 06/12/2008 | US20080139592 Administering carboxyamidotriazole or 5-(amino)-1,2,3-triazole orotate as angiogenesis inhibitor; treatment of vision defects, retinopathy, neovascularization, blood disorder, leukemia, granuloma, arthritis, psoriasis; antidiabetic, antitumor, anticarcinogenric, antimetastasis, and wound healing agents; |
| 06/12/2008 | US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents |
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080139451 Compositions for Treating Ocular Surface Pathologies |
| 06/12/2008 | US20080138849 Use of mdck cell line to predict corneal penetration of drugs |
| 06/12/2008 | US20080138382 Biocompatible intraocular implants include a steroid and a polymer; biodegradable; eye implantable drug delivery systems; few or no negative side effects |
| 06/12/2008 | US20080138350 Process for use of fluoroquinolones to reduce or modulate inflammation due to eye disease or ophthalmic surgery |
| 06/12/2008 | US20080138310 As wetting agents and polyquaternium" microbiocides; preferably ethylene oxide-1,2-butylene oxide copolymer |
| 06/12/2008 | CA2671524A1 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
| 06/11/2008 | EP1930344A1 Polypeptide having anti-angiogenic activity |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930046A1 Retinol binding protein and transthyretin modulators for treating diabetes |
| 06/11/2008 | EP1930028A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
| 06/11/2008 | EP1930000A1 Combination of organic compounds |
| 06/11/2008 | EP1929996A2 Ophthalmic emulsions containing an immunosuppressive agent |
| 06/11/2008 | EP1928474A1 Use of glucosylated hydroxystilbenes for the prevention and treatment of eye pathologies |
| 06/11/2008 | EP1928470A2 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 06/11/2008 | EP1928462A1 Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 06/11/2008 | EP1928440A2 Treatment of eye disorders with sirtuin modulators |
| 06/11/2008 | EP1928439A2 Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear |
| 06/11/2008 | EP1928420A1 Treatment of inflammation and vascular abnormalities of the eye |
| 06/11/2008 | EP1928405A1 Pharmaceutical compositions for the treatment of inner ear disorders |
| 06/11/2008 | EP1740186B1 Biodegradable intraocular implants containing prostamides |
| 06/11/2008 | EP1451184B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1368032B1 Excitatory amino acid receptor antagonists |
| 06/11/2008 | CN101198355A Agent for prevention or treatment of glaucoma |
| 06/11/2008 | CN101198354A Preventive or remedy for glaucoma |
| 06/11/2008 | CN101195604A 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
| 06/11/2008 | CN101195025A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
| 06/11/2008 | CN101194983A Dropping pills for treating sudden deafness and method for preparing the same |
| 06/11/2008 | CN101194981A Powder medicament for treating otitis media chronica |
| 06/11/2008 | CN101194980A Powder medicament for treating otitis media suppurative |
| 06/11/2008 | CN101194978A Orally taken Chinese medicine composition for treating otitis medium |
| 06/11/2008 | CN100393335C Use of composition in preparing medicament for preventing and treating red eye, aversion to light, swell pain |
| 06/11/2008 | CN100393303C Vitamin A liposome artificial lacrimal eye drops |
| 06/10/2008 | US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384925 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
| 06/10/2008 | CA2474280C Compositions containing alpha-2-adrenergic agonist components |
| 06/10/2008 | CA2376121C Stable xylometazoline and oxymetazoline solution |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2311530C Nasal solutions |
| 06/10/2008 | CA2286330C Anti-vegf antibodies |
| 06/05/2008 | WO2008066494A1 THERAPEUTIC USES OF β-ANTAGONISTS |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008065754A1 Substituted carbinol compound |
| 06/05/2008 | WO2008065429A1 Method for delivering gene therapy vectors to the optic nerve head |
| 06/05/2008 | WO2008024765B1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 06/05/2008 | WO2008005295A3 Modulators of muscarinic receptors |
| 06/05/2008 | WO2007112322A3 Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
| 06/05/2008 | WO2007106915A3 Antibodies to egfl7 and methods for their use |
| 06/05/2008 | US20080132825 Transcutaneous infusion of carbon dioxide for local relief of pain and other ailments |
| 06/05/2008 | US20080132706 Compounds as PDE IV and TNF Inhibitors |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132576 1-(3-chloro-2-fluorobenzyl)-3-(2-hydroxyethyl)-thiourea; analgesics; gastrointestinal disorders, chronic pain, glaucoma, vision defects; rheumatoid arthritis, spondylitis, gouty arthritis, osteoarthritis, juvenile arthritis; autoimmune diseases: lupus erythematosus |
| 06/05/2008 | US20080132528 Kinase inhibitors and methods for using the same |
| 06/05/2008 | US20080132512 Combination of Brimonidine and Timolol for Topical Ophthalmic Use |
| 06/05/2008 | US20080132508 compound that inhibits glycosphingolipid synthesis; includes PPMP, PDMP, or NB-DGJ or any derivative or analog thereof or any derivative of ceramide that inhibits glycosphingolipid metabolism |
| 06/05/2008 | US20080132481 Use of 3-substituted amino-2-carboxy-substituted indoles or benzo(b)thiophenes or esters thereof that modulate T helper (Th) cells; treating allergy, asthma, rhinitis, dermatitis, B-cell lymphomas, tumors and diseases associated with bacterial, rhinovirus or respiratory syncytial virus (RSV) infections |
| 06/05/2008 | US20080132464 Selective induction of apoptosis to treat ocular disease |
| 06/05/2008 | US20080132463 Pharmaceutical use of alpha antigen or alpha antigen gene |
| 06/05/2008 | US20080132451 Modulation of polysialylated neural adhesion molecules (psa-ncam) as a regulator of ocular disease |
| 06/05/2008 | US20080132444 Ocular Agent Delivery Systems |
| 06/05/2008 | US20080131516 Granule formation |
| 06/05/2008 | US20080131511 Use of(-)-S isomer of 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane or salt thereof (YM-796) to accelerate tear and salivary fluid secretion without accompanying sweating; sustained release with a hydrophilic base and a polymeric hydrogel as carrier |